Pricing Log in Create free account

Burning Rock Biotech Limited Sponsored ADR (BNR) vs Precipio, Inc. (PRPO)

Burning Rock Biotech Limited Sponsored ADR and Precipio, Inc. are both Diagnostics & Research companies. Burning Rock Biotech Limited Sponsored ADR is the larger, with a market value of $137.1M against $40.4M — 3.4× the size. Precipio, Inc. grew revenue faster over the last twelve months: 28.0% against −0.14%. Precipio, Inc. has the higher net margin (−4.47% vs −13.5%) and the higher return on invested capital (−7.63% vs −50.7%). Across the 18 metrics below, Precipio, Inc. leads on 15 and Burning Rock Biotech Limited Sponsored ADR on 3.

Valuation

Metric BNR PRPO Diagnostics & Research median
P/E n/m n/m 35.56
P/S 18.73 1.41 4.37
P/B 18.81 2.59 3.06
Price to free cash flow n/m 48.43 35.76
EV/EBITDA n/m 122.01 24.35
EV/Sales 17.89 1.33 5.51
Earnings yield (4.09%) (2.99%) (1.89%)
Free cash flow yield (1.06%) 2.06% (0.15%)

Profitability

Metric BNR PRPO Diagnostics & Research median
Gross margin 74.50% 44.11% 50.89%
Operating margin (12.95%) (5.68%) (8.57%)
Net margin (13.51%) (4.47%) (6.37%)
Free cash flow margin (3.00%) 2.90% 0.00%
Return on equity (13.08%) (8.98%) (2.92%)
Return on assets (8.81%) (6.05%) (6.71%)
Return on invested capital (50.66%) (7.63%) 0.00%

Growth

Metric BNR PRPO Diagnostics & Research median
Revenue growth (TTM) (0.14%) 28.04% 7.69%
EPS growth (last fiscal year) 84.16% 92.15% 25.92%
Revenue growth, 5-year CAGR 3.21% 31.60% 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BNR PRPO Diagnostics & Research median
Debt to equity 0.00 0.07 0.11
Current ratio 3.05 1.77 2.02
Net debt to EBITDA 14.48 (3.30) 0.70

Dividend

Metric BNR PRPO Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric BNR PRPO Diagnostics & Research median
Market cap 137.12m 40.35m 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack